These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 711071)

  • 61. Effects of butylated hydroxyanisole (BHA) and butylated hydroxytoluene (BHT) on the acetylation of 2-aminofluorene and DNA-2-aminofluorene adducts in the rat.
    Chung JG
    Toxicol Sci; 1999 Oct; 51(2):202-10. PubMed ID: 10543022
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Vitamin K deficiency in male rats fed diets containing butylated hydroxytoluene (BHT).
    Suzuki H; Nakao T; Hiraga K
    Toxicol Appl Pharmacol; 1979 Sep; 50(2):261-6. PubMed ID: 92074
    [No Abstract]   [Full Text] [Related]  

  • 63. The dose-dependent effect of BHT (butylated hydroxytoluene) on vitamin K-dependent blood coagulation in rats.
    Cottrell S; Andrews CM; Clayton D; Powell CJ
    Food Chem Toxicol; 1994 Jul; 32(7):589-94. PubMed ID: 8045471
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Simultaneous inhibition of liver carcinogenicity and enhancement of bladder carcinogenicity of N-2-fluorenylacetamide by butylated hydroxytoluene.
    Williams GM; Maeura Y; Weisburger JH
    Cancer Lett; 1983 May; 19(1):55-60. PubMed ID: 6303561
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Biochemical and pathological differences in hepatic response to chronic feeding of safrole and butylated hydroxytoluene to rats.
    Gray TJ; Parke DV; Grasso P; Crampton RF
    Biochem J; 1972 Nov; 130(2):91P. PubMed ID: 4664617
    [No Abstract]   [Full Text] [Related]  

  • 66. Effects of butylated hydroxytoluene (BHT) on the level of glutathione and the activity of glutathione-S-transferase in rat liver.
    Nakagawa Y; Hiraga K; Suga T
    J Pharmacobiodyn; 1981 Oct; 4(10):823-6. PubMed ID: 7320832
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Antimicrobial activity of phenolic antioxidants].
    Turcotte P; Saheb SA
    Can J Microbiol; 1978 Nov; 24(11):1306-20. PubMed ID: 743641
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Short-term effects of butylated hydroxytoluene on the Wistar rat liver, urinary bladder and thyroid gland.
    Briggs D; Lok E; Nera EA; Karpinski K; Clayson DB
    Cancer Lett; 1989 Jul; 46(1):31-6. PubMed ID: 2736505
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Biological fate of butylated hydroxytoluene (BHT); binding in vivo of BHT to macromolecules of rat liver.
    Nakagawa Y; Hiraga K; Suga T
    Chem Pharm Bull (Tokyo); 1979 Feb; 27(2):442-6. PubMed ID: 445679
    [No Abstract]   [Full Text] [Related]  

  • 70. Inhibition of the hepatocarcinogenicity of aflatoxin B1 in rats by low levels of the phenolic antioxidants butylated hydroxyanisole and butylated hydroxytoluene.
    Williams GM; Iatropoulos MJ
    Cancer Lett; 1996 Jun; 104(1):49-53. PubMed ID: 8640745
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Butylated hydroxytoluene pretreatment protects against cytotoxicity and reduces covalent binding of aflatoxin B1 in primary hepatocyte cultures.
    Salocks CB; Hsieh DP; Byard JL
    Toxicol Appl Pharmacol; 1981 Jun; 59(2):331-45. PubMed ID: 6789502
    [No Abstract]   [Full Text] [Related]  

  • 72. Biological fate of butylated hydroxytoluene (BHT): subcellular distribution of BHT in rat liver.
    Nakagawa Y; Ikawa M; Hiraga K
    Chem Pharm Bull (Tokyo); 1978 Feb; 26(2):374-8. PubMed ID: 639170
    [No Abstract]   [Full Text] [Related]  

  • 73. Effects of butylated hydroxytoluene (BHT) on biliary excretion of xenobiotics and bile flow in rats.
    Choe SY; Kim HM; Yang KH
    Drug Chem Toxicol; 1984; 7(2):149-65. PubMed ID: 6434281
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Effect of butylated hydroxytoluene and butylated hydroxyanisole on the mutagenicity of 3,2'-dimethyl-4-aminobiphenyl.
    Reddy BS; Sharma C; Mathews L
    Nutr Cancer; 1983; 5(3-4):153-8. PubMed ID: 6366755
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Early alterations in plasma esterases with associated pathology following oral administration of diethylnitrosamine and butylated hydroxytoluene singly or in combination.
    Tyndall RL; Colyer S; Clapp N
    Int J Cancer; 1975 Jul; 16(1):184-91. PubMed ID: 1176193
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Biological fate of butylated hydroxytoluene (BHT); binding in vitro of BHT to liver microsomes.
    Nakagawa Y; Hiraga K; Suga T
    Chem Pharm Bull (Tokyo); 1979 Feb; 27(2):480-5. PubMed ID: 445683
    [No Abstract]   [Full Text] [Related]  

  • 77. Selective sex-related modification of diethylnitrosamine-induced carcinogenesis in BALB/c mice by concomitant administration of butylated hydroxytoluene.
    Clapp NK; Tyndall RL; Satterfield LC; Klima WC; Bowles ND
    J Natl Cancer Inst; 1978 Jul; 61(1):177-82. PubMed ID: 276624
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Dose-dependent effects of butylated hydroxyanisole, butylated hydroxytoluene and ethoxyquin in induction of foci of rat liver cells containing the placental form of glutathione S-transferase.
    Thamavit W; Tatematsu M; Ogiso T; Mera Y; Tsuda H; Ito N
    Cancer Lett; 1985 Jul; 27(3):295-303. PubMed ID: 2861889
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Species differences in the haemorrhagic response to butylated hydroxytoluene.
    Takahashi O; Hayashida S; Hiraga K
    Food Cosmet Toxicol; 1980 Jun; 18(3):229-35. PubMed ID: 7419139
    [No Abstract]   [Full Text] [Related]  

  • 80. Cytotoxicity of butylated hydroxyanisole and butylated hydroxytoluene in isolated rat hepatocytes.
    Thompson D; Moldéus P
    Biochem Pharmacol; 1988 Jun; 37(11):2201-7. PubMed ID: 3377819
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.